Unconjugated Human HLA-A*02:01&B2M&WT-1 (RMFPNAPYL) Complex Protein (Monomer, MALS verified)

Artikelnummer: ABS-HL1-H82EB-25UG
Artikelname: Unconjugated Human HLA-A*02:01&B2M&WT-1 (RMFPNAPYL) Complex Protein (Monomer, MALS verified)
Artikelnummer: ABS-HL1-H82EB-25UG
Hersteller Artikelnummer: HL1-H82Eb-25ug
Alternativnummer: ABS-HL1-H82EB-25UG
Hersteller: AcroBiosystems
Wirt: Human
Kategorie: Proteine/Peptide
Spezies Reaktivität: Human
Konjugation: Unconjugated
Wilms tumor gene 1 (WT1),is an attractive target antigen for leukemia and solid cancer. WT1specific adoptive immunotherapy has developed for tumor treatment in recent years. WT1 has been proved wildly expressed in breast, colon and ovarian cancer. It participates in cell growth, differentiation and apoptosis regulation. The Human HLAA*0201 WT1 (RMFPNAPYL) complex Protein is a complex of HLAA*0201 of the MHC Class I, B2M and RMFPNAPYL peptide of the WT1. - Proteine/Peptide
Molekulargewicht: 36.3 kDa and 11.7 kDa
Tag: C-10*His & C-Avi
NCBI: 59606
Puffer: PBS, pH7.4
Reinheit: 90%
Formulierung: Powder
Target-Kategorie: HLA-A*0201 & B2M & WT-1 (RMFPNAPYL)
Immobilized Unconjugated Human HLA-A*02:01&B2M&WT-1 (RMFPNAPYL) Complex Protein (Cat. No. HL1-H82Eb) at 1 µg/mL (100 µL/well) can bind Monoclonal Anti-HLA class I Antibody, Human IgG1 (W632) with a linear range of 0.06-2 ng/mL (QC tested).
Immobilized Unconjugated Human HLA-A*02:01&B2M&WT-1 (RMFPNAPYL) Complex Protein (Cat. No. HL1-H82Eb) at 1 µg/mL (100 µL/well) can bind Monoclonal Anti-B2M Antibody, Human IgG1 with a linear range of 0.06-1 ng/mL (Routinely tested).
Unconjugated Human HLA-A*02:01&B2M&WT-1 (RMFPNAPYL) Complex Protein on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 90%.